Sci-Tech North Carolina: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech North Carolina.

Press releases published on September 29, 2026

Sep. 29, 2026

SaverOne Awarded U.S. Patent for Automated Sensor Fusion Calibration and Maintenance: Strengthening its IP Protection as Fleet Deployments Scale

Indeterminate GlobeNewswire

Sep. 29, 2026

3 E Network Launches Hardware Procurement Evaluation for Finnish AI Compute Center

Indeterminate GlobeNewswire

Sep. 29, 2026

Cognition Therapeutics Schedules a Type C Meeting with FDA to Align on Endpoints for Phase 3 Trial of Zervimesine (CT1812) in DLB

Indeterminate GlobeNewswire

Sep. 29, 2026

Cartesian Therapeutics Announces Additional Retreatment Data for Descartes-08 Highlighting Deep and Durable Responses in Patients with Myasthenia Gravis

Indeterminate GlobeNewswire

Sep. 29, 2026

Cellectar Biosciences to Present Compelling Efficacy Data from Phase 2 CLOVER WaM Subset Analysis of Iopofosine I 131 in Patients Refractory/Resistant to BTK Inhibitor Therapy at International Workshop for Waldenström Macroglobulinemia

Indeterminate GlobeNewswire

Sep. 29, 2026

Medicus Pharma Submits Optimized Teverelix® Registrational Protocol to FDA to Create Partner Ready Program in Advanced Prostate Cancer

Indeterminate GlobeNewswire

Sep. 29, 2026

TruGolf and Polymath to Present at The ThinkEquity Conference in New York on October 15

Indeterminate GlobeNewswire

Sep. 29, 2026

uniQure Announces Additional Data from Ongoing Phase I/II Studies of ifezuntirgene inilparvovec (AMT-130) in Huntington’s Disease Showing Continued Slowing of Disease Progression

Indeterminate GlobeNewswire

Sep. 29, 2026

Kraig Biocraft Laboratories Ships its First Commercial Spider Silk Yarn Order for Performance Sports Brand

Indeterminate GlobeNewswire

Sep. 29, 2026

Immix Biopharma Announces Pricing of $125 Million Underwritten Offering of Common Stock

Indeterminate GlobeNewswire

Sep. 29, 2026

Boehringer Ingelheim investments into sustainability-related programs and health partnerships to reach EUR 500 million

Indeterminate GlobeNewswire

Sep. 29, 2026

PolarityBio’s Phase 3 COVER DFUS II Trial Selected for First-to-Podium Presentation at SAWC Fall 2026

Indeterminate GlobeNewswire

Sep. 29, 2026

Ocugen to Participate in Upcoming October Investor and Industry Conferences

Indeterminate GlobeNewswire

Sep. 29, 2026

BeyondSpring Announces FDA Fast Track Designation for Plinabulin in Post-ICI Non-Squamous NSCLC and Strategic Transaction to Advance Global Phase 3 DUBLIN-4 Trial Toward Planned Interim Analysis

Indeterminate GlobeNewswire

Sep. 29, 2026

Invivyd Announces Positive Topline Results from LIBERTY Phase 3 Study Demonstrating VYD2311 Safety and Tolerability Superior to mRNA-based COVID-19 Vaccine; Announces Regulatory Submission Plans for VYD2311

Indeterminate GlobeNewswire

Sep. 29, 2026

EliseAI Raises $350 Million at $4 Billion Valuation to Bring AI Deeper Into Housing and Healthcare Operations

Indeterminate GlobeNewswire

Sep. 29, 2026

Aurora Mobile's GPTBots.ai Helps Ruko Cut Support Ticket Response Time from Two Hours to Under 10 Minutes

Indeterminate GlobeNewswire

Sep. 29, 2026

Cascade Prodrug Inc. Appoints Kenneth Mandell, M.D., Ph.D. to Board of Directors

Indeterminate GlobeNewswire

Sep. 29, 2026

Nurix Therapeutics Announces Achievement of $7 Million Milestone Under Strategic Collaboration with Pfizer

Indeterminate GlobeNewswire

Sep. 29, 2026

Aquestive Therapeutics Strengthens Board of Directors with Appointment of Richard Daly

Indeterminate GlobeNewswire